RARE icon

Ultragenyx Pharmaceutical
RARE

Overview Fund Activity

163 hedge funds and large institutions have $2.01B invested in Ultragenyx Pharmaceutical in 2017 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 58 increasing their positions, 47 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
163
Holders Change
+9
Holders Change %
+5.84%
% of All Funds
3.7%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
30
Increased
58
Reduced
47
Closed
21
Calls
$5.25M
Puts
$8.42M
Net Calls
-$3.17M
Net Calls Change
+$1.44M

Top Buyers

1
Capital Research Global Investors
1
Capital Research Global Investors
California
$231M
2
Wellington Management Group
2
Wellington Management Group
Massachusetts
$272M
3
Federated Hermes
3
Federated Hermes
Pennsylvania
$51.1M
4
Capital International Investors
4
Capital International Investors
California
$166M
5
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$98.4M

Top Sellers

1
EAM
1
Eagle Asset Management
Florida
$0
2
RFS
2
Rockefeller Financial Services
New York
$121K
3
Jennison Associates
3
Jennison Associates
New York
$0
4
O
4
OppenheimerFunds
New York
$0
5
CI
5
Capital International
California
$2.88M
Name Holding Trade Value Shares
Change 		Shares
Change %
WPA
176
West Paces Advisors
Georgia
– -$13.6K -255 Closed
FPS
177
Fieldpoint Private Securities
Connecticut
– -$11K -200 Closed
CHP
178
Cable Hill Partners
Oregon
– -$4K -80 Closed
NFG
179
Next Financial Group
Texas
– -$4K -65 Closed
MPWT
180
MassMutual Private Wealth & Trust
Connecticut
– -$2.72K -51 Closed
4 5 6 7
8